Literature DB >> 21238714

ACTH-dependent Cushing syndrome: The potential benefits of simultaneous bilateral posterior retroperitoneoscopic adrenalectomy.

Celestino Pio Lombardi, Marco Raffaelli, Carmela de Crea, Rocco Bellantone, Alessandra Fusco, Antonio Bianchi, Alfredo Pontecorvi, Laura de Marinis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21238714     DOI: 10.1016/j.surg.2010.06.005

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  5 in total

1.  Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas.

Authors:  Pier Francesco Alesina; Jakob Hinrichs; Beate Meier; Kurt W Schmid; Hartmut P H Neumann; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2011-09-21       Impact factor: 3.445

2.  Carbon dioxide absorption during retroperitoneoscopic adrenalectomy: comparison between monolateral and synchronous bilateral approaches.

Authors:  Valter Perilli; Paola Aceto; Giovanni Punzo; Celestino Pio Lombardi; Rocco Bellantone; Liliana Sollazzi
Journal:  Updates Surg       Date:  2018-12-01

3.  Retroperitoneoscopic adrenalectomy: tips and tricks.

Authors:  Carmela De Crea; Marco Raffaelli; Gerardo D'Amato; Pietro Princi; Pierpaolo Gallucci; Rocco Bellantone; Celestino Pio Lombardi
Journal:  Updates Surg       Date:  2017-06-13

4.  Posterior retroperitoneoscopic adrenal surgery for clinical and subclinical Cushing's syndrome in patients with bilateral adrenal disease.

Authors:  Aoife J Lowery; Barbara Seeliger; Pier F Alesina; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2017-02-28       Impact factor: 3.445

5.  Synchronous bilateral adrenalectomy for Cushing's syndrome: laparoscopic versus posterior retroperitoneoscopic versus robotic approach.

Authors:  Marco Raffaelli; Laurent Brunaud; Carmela De Crea; Guillaume Hoche; Luigi Oragano; Laurent Bresler; Rocco Bellantone; Celestino P Lombardi
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.